These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15814247)

  • 1. Preparation of a PLA-PEG block copolymer using a PLA derivative with a formyl terminal group and its application to nanoparticulate formulation.
    Sasatsu M; Onishi H; Machida Y
    Int J Pharm; 2005 Apr; 294(1-2):233-45. PubMed ID: 15814247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo characterization of nanoparticles made of MeO-PEG amine/PLA block copolymer and PLA.
    Sasatsu M; Onishi H; Machida Y
    Int J Pharm; 2006 Jul; 317(2):167-74. PubMed ID: 16621360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and biodisposition of methoxypolyethylene glycol amine-poly(DL-lactic acid) copolymer nanoparticles loaded with pyrene-ended poly(DL-lactic acid).
    Sasatsu M; Onishi H; Machida Y
    Int J Pharm; 2008 Jun; 358(1-2):271-7. PubMed ID: 18448290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
    Sant S; Poulin S; Hildgen P
    J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
    Park SJ; Kim SH
    J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEG-PLA block copolymer as potential drug carrier: preparation and characterization.
    Ben-Shabat S; Kumar N; Domb AJ
    Macromol Biosci; 2006 Dec; 6(12):1019-25. PubMed ID: 17128420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micelle-like nanoparticles of PLA-PEG-PLA triblock copolymer as chemotherapeutic carrier.
    Venkatraman SS; Jie P; Min F; Freddy BY; Leong-Huat G
    Int J Pharm; 2005 Jul; 298(1):219-32. PubMed ID: 15946811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
    Zhang Z; Feng SS
    Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylenglycol-co-poly-D,L-lactide copolymer based microspheres: preparation, characterization and delivery of a model protein.
    Dorati R; Genta I; Tomasi C; Modena T; Colonna C; Pavanetto F; Perugini P; Conti B
    J Microencapsul; 2008 Aug; 25(5):330-8. PubMed ID: 18465305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
    Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
    Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of biodegradable nanoparticles of tri-block PLA-PEG-PLA copolymer and determination of factors controlling the particle size using artificial neural network.
    Asadi H; Rostamizadeh K; Salari D; Hamidi M
    J Microencapsul; 2011; 28(5):406-16. PubMed ID: 21736525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of a nanoparticulate formulation composed of PEG-PLA and PLA as anti-inflammatory agents.
    Ishihara T; Takahashi M; Higaki M; Mizushima Y; Mizushima T
    Int J Pharm; 2010 Jan; 385(1-2):170-5. PubMed ID: 19837147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-situ formation of biodegradable hydrogels by stereocomplexation of PEG-(PLLA)8 and PEG-(PDLA)8 star block copolymers.
    Hiemstra C; Zhong Z; Li L; Dijkstra PJ; Feijen J
    Biomacromolecules; 2006 Oct; 7(10):2790-5. PubMed ID: 17025354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of core--shell-type nanoparticles carrying stable radicals in the core.
    Yoshitomi T; Miyamoto D; Nagasaki Y
    Biomacromolecules; 2009 Mar; 10(3):596-601. PubMed ID: 19191564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
    Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
    Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable thermo-sensitive nanoparticles from poly(L-lactic acid)/poly(ethylene glycol) alternating multi-block copolymer for potential anti-cancer drug carrier.
    Na K; Lee KH; Lee DH; Bae YH
    Eur J Pharm Sci; 2006 Feb; 27(2-3):115-22. PubMed ID: 16253487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel thymopentin release systems prepared from bioresorbable PLA-PEG-PLA hydrogels.
    Zhang Y; Wu X; Han Y; Mo F; Duan Y; Li S
    Int J Pharm; 2010 Feb; 386(1-2):15-22. PubMed ID: 19895878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLA-PEG particles as nasal protein carriers: the influence of the particle size.
    Vila A; Sánchez A; Evora C; Soriano I; McCallion O; Alonso MJ
    Int J Pharm; 2005 Mar; 292(1-2):43-52. PubMed ID: 15725552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characterization of Me. PEG-PLA copolymer nanoparticles prepared by modified spontaneous emulsion-solvent evaporation].
    Dong J; Liu MX; Yang YJ; Xu HB; Yang XL
    Yao Xue Xue Bao; 2004 Sep; 39(9):677-80. PubMed ID: 15606012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.